Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Modified cooling xiaofeng powder is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Chengdu University of Traditional Chinese Medicine for the treatment of psoriasis vulgaris, specifically the recurrent blood-heat syndrome. The formula is based on the 'Fuxie' theory, which focuses on clearing 'heat evil' and nourishing the kidney to address the underlying causes of disease recurrence. Its therapeutic mechanism involves immunomodulation, specifically regulating the balance and activity of helper T cell (Th) subsets, including Th1, Th2, and Th17 cells, along with their associated cytokines and transcription factors. By modulating these immune pathways, the powder aims to control disease progression and maintain long-term remission in patients with psoriasis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on modified cooling xiaofeng powder.